173 related articles for article (PubMed ID: 25840345)
1. Deletion of ADAMTS5 does not affect aggrecan or versican degradation but promotes glucose uptake and proteoglycan synthesis in murine adipose derived stromal cells.
Gorski DJ; Xiao W; Li J; Luo W; Lauer M; Kisiday J; Plaas A; Sandy J
Matrix Biol; 2015 Sep; 47():66-84. PubMed ID: 25840345
[TBL] [Abstract][Full Text] [Related]
2. Murine tendon function is adversely affected by aggrecan accumulation due to the knockout of ADAMTS5.
Wang VM; Bell RM; Thakore R; Eyre DR; Galante JO; Li J; Sandy JD; Plaas A
J Orthop Res; 2012 Apr; 30(4):620-6. PubMed ID: 21928430
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.
Demircan K; Topcu V; Takigawa T; Akyol S; Yonezawa T; Ozturk G; Ugurcu V; Hasgul R; Yigitoglu MR; Akyol O; McCulloch DR; Hirohata S
Biomed Res Int; 2014; 2014():693746. PubMed ID: 25101296
[TBL] [Abstract][Full Text] [Related]
4. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models.
Li J; Anemaet W; Diaz MA; Buchanan S; Tortorella M; Malfait AM; Mikecz K; Sandy JD; Plaas A
J Orthop Res; 2011 Apr; 29(4):516-22. PubMed ID: 21337391
[TBL] [Abstract][Full Text] [Related]
5. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis.
Hattori N; Carrino DA; Lauer ME; Vasanji A; Wylie JD; Nelson CM; Apte SS
J Biol Chem; 2011 Sep; 286(39):34298-310. PubMed ID: 21828051
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS5-mediated aggrecanolysis in murine epiphyseal chondrocyte cultures.
Stewart MC; Fosang AJ; Bai Y; Osborn B; Plaas A; Sandy JD
Osteoarthritis Cartilage; 2006 Apr; 14(4):392-402. PubMed ID: 16406703
[TBL] [Abstract][Full Text] [Related]
7. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
[TBL] [Abstract][Full Text] [Related]
10. Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5.
Foulcer SJ; Nelson CM; Quintero MV; Kuberan B; Larkin J; Dours-Zimmermann MT; Zimmermann DR; Apte SS
J Biol Chem; 2014 Oct; 289(40):27859-73. PubMed ID: 25122765
[TBL] [Abstract][Full Text] [Related]
11. Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development.
Voros G; Sandy JD; Collen D; Lijnen HR
Biochim Biophys Acta; 2006 Dec; 1760(12):1837-44. PubMed ID: 17011710
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression.
McCulloch DR; Nelson CM; Dixon LJ; Silver DL; Wylie JD; Lindner V; Sasaki T; Cooley MA; Argraves WS; Apte SS
Dev Cell; 2009 Nov; 17(5):687-98. PubMed ID: 19922873
[TBL] [Abstract][Full Text] [Related]
13. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.
Jayasuriya CT; Goldring MB; Terek R; Chen Q
Arthritis Res Ther; 2012 Sep; 14(5):R197. PubMed ID: 22967398
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
Powell AJ; Little CB; Hughes CE
Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444
[TBL] [Abstract][Full Text] [Related]
15. Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor β1 (TGFβ1) signaling.
Velasco J; Li J; DiPietro L; Stepp MA; Sandy JD; Plaas A
J Biol Chem; 2011 Jul; 286(29):26016-27. PubMed ID: 21566131
[TBL] [Abstract][Full Text] [Related]
16.
Dupuis LE; Nelson EL; Hozik B; Porto SC; Rogers-DeCotes A; Fosang A; Kern CB
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2067-2081. PubMed ID: 31366218
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS5 is required for biomechanically-stimulated healing of murine tendinopathy.
Bell R; Li J; Shewman EF; Galante JO; Cole BJ; Bach BR; Troy KL; Mikecz K; Sandy JD; Plaas AH; Wang VM
J Orthop Res; 2013 Oct; 31(10):1540-8. PubMed ID: 23754494
[TBL] [Abstract][Full Text] [Related]
18. Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling.
Fava M; Barallobre-Barreiro J; Mayr U; Lu R; Didangelos A; Baig F; Lynch M; Catibog N; Joshi A; Barwari T; Yin X; Jahangiri M; Mayr M
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1537-1548. PubMed ID: 29622560
[TBL] [Abstract][Full Text] [Related]
19. Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
Durigova M; Troeberg L; Nagase H; Roughley PJ; Mort JS
Eur Cell Mater; 2011 Jan; 21():31-45. PubMed ID: 21225593
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.
Little CB; Mittaz L; Belluoccio D; Rogerson FM; Campbell IK; Meeker CT; Bateman JF; Pritchard MA; Fosang AJ
Arthritis Rheum; 2005 May; 52(5):1461-72. PubMed ID: 15880348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
